HIGHLIGHTS
- who: Michele Magnocavallo and colleagues from the Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Policlinico Universitario have published the research: Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy, in the Journal: (JOURNAL) of 22/Dec/2020
- what: The aim of this review is to shed light on the applications of DOAC in CKD patients especially in ESRD patients. The aim of this review is to evaluate how treatment with DOACs affects cluded patients on dialysis, those with an eGFR and amp;lt; 25-30 mL/min . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.